Kevin J. Hodgetts

1.0k citations

32 papers · 769 indexed · h-index 16

Organic Chemistry top 5%
Molecular Biology
Cellular and Molecular Neuroscience top 10%
Physiology
Pharmacology

Co-authors: Mark T. Kershaw Elliot J. Androphy Robbin Brodbeck Stéphane De Lombaert Chien‐liang Glenn Lin Xuechao Xing Gregory D. Cuny Marcie A. Glicksman
Topics: Neuroscience and Neuropharmacology Research (5 papers)Neurogenetic and Muscular Disorders Research (5 papers)RNA modifications and cancer (5 papers)
Cited by: Organic Chemistry Biological Psychiatry Cellular and Molecular Neuroscience
Journals: The Journal of Experimental Medicine Annals of Neurology Scientific Reports
Partner nations: United States Ireland United Kingdom

In The Last Decade

Kevin J. Hodgetts

31 papers receiving 740 citations

Peers

Countries citing papers authored by Kevin J. Hodgetts

Since Specialization

Citations

This map shows the geographic impact of Kevin J. Hodgetts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin J. Hodgetts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin J. Hodgetts more than expected).

Fields of papers citing papers by Kevin J. Hodgetts

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin J. Hodgetts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin J. Hodgetts. The network helps show where Kevin J. Hodgetts may publish in the future.

Co-authorship network of co-authors of Kevin J. Hodgetts

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin J. Hodgetts. A scholar is included among the top collaborators of Kevin J. Hodgetts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin J. Hodgetts. Kevin J. Hodgetts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Lipase regulation of cellular fatty acid homeostasis as a Parkinson’s disease therapeutic strategy 2022 ·npj Parkinson s Disease ·Saranna Fanning,(unknown),(unknown),Jooyoung Jeong,(unknown),Joon Yoon,Gary P. H. Ho,Julián Ávila-Pacheco,Ulf Dettmer,Lei Liu,Clary B. Clish,Kevin J. Hodgetts,John N. Hutchinson,Christina Muratore,Guy A. Caldwell,Kim A. Caldwell,Dennis J. Selkoe	13
2	Short-duration splice promoting compound enables a tunable mouse model of spinal muscular atrophy 2020 ·Life Science Alliance ·(unknown),Kevin J. Hodgetts,Hrvoje Lusic,(unknown),Erkan Y. Osman,Christian L. Lorson,Elliot J. Androphy	1
3	A Stearoyl–Coenzyme A Desaturase Inhibitor Prevents Multiple Parkinson Disease Phenotypes in α‐Synuclein Mice 2020 ·Annals of Neurology ·Silke Nuber,(unknown),Molly M. Rajsombath,(unknown),Xiaoping Hronowski,Junmin Wang,Kevin J. Hodgetts,Liubov S. Kalinichenko,Christian P. Müller,(unknown),Jürgen Winkler,Andreas Weihofen,Thibaut Imberdis,Ulf Dettmer,Saranna Fanning,Dennis J. Selkoe	46
4	Intraperitoneal delivery of a novel drug‐like compound improves disease severity in severe and intermediate mouse models of Spinal Muscular Atrophy 2019 ·Scientific Reports ·Erkan Y. Osman,(unknown),Rachel Kline,Jonathan J. Cherry,Kevin J. Hodgetts,Christian L. Lorson,Elliot J. Androphy	6
5	Pyridazine-derivatives Enhance Structural and Functional Plasticity of Tripartite Synapse Via Activation of Local Translation in Astrocytic Processes 2018 ·Neuroscience ·(unknown),Fangli Zhao,Xueqin Wang,Zan Xu,(unknown),Candice C. Askwith,Kevin J. Hodgetts,Chien‐liang Glenn Lin	15
6	Optimization of a series of heterocycles as survival motor neuron gene transcription enhancers 2017 ·Bioorganic & Medicinal Chemistry Letters ·Sung‐Woon Choi,(unknown),(unknown),(unknown),(unknown),(unknown),Hongxia Li,Jonathan J. Cherry,(unknown),Xuechao Xing,Marcie A. Glicksman,Gregory D. Cuny,Christian L. Lorson,(unknown),Kevin J. Hodgetts	3
7	Small Molecules in Development for the Treatment of Spinal Muscular Atrophy 2016 ·Journal of Medicinal Chemistry ·(unknown),Elliot J. Androphy,Kevin J. Hodgetts	53
8	Pyrido[2,3-b]pyrazines, discovery of TRPV1 antagonists with reduced potential for the formation of reactive metabolites 2010 ·Bioorganic & Medicinal Chemistry Letters ·Kevin J. Hodgetts,Charles A. Blum,Timothy M. Caldwell,Rajagopal Bakthavatchalam,Xiaozhang Zheng,(unknown),James E. Krause,Daniel N. Cortright,Marci Crandall,Beth Murphy,Susan Boyce,A. Brian Jones,Bertrand L. Chenard	10
9	Aminoquinazolines as TRPV1 antagonists: Modulation of drug-like properties through the exploration of 2-position substitution 2008 ·Bioorganic & Medicinal Chemistry Letters ·Charles A. Blum,Xiaozhang Zheng,Harry L. Brielmann,Kevin J. Hodgetts,Rajagopal Bakthavatchalam,Jayaraman Chandrasekhar,James E. Krause,Daniel N. Cortright,David J. Matson,Marci Crandall,(unknown),Lawrence K. Fung,(unknown),Mark T. Kershaw,Stéphane De Lombaert,Bertrand L. Chenard	13
10	1-Benzylbenzimidazoles: The discovery of a novel series of bradykinin B1 receptor antagonists 2008 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Jayaraman Chandrasekhar,David C. Ihle,David J. Wustrow,Bertrand L. Chenard,James E. Krause,Alan Hutchison,(unknown),(unknown),Daniel N. Cortright,Daniel C. Broom,Mark T. Kershaw,(unknown),Yao Peng,Kevin J. Hodgetts	9
11	2-Arylpyrimidines: Novel CRF-1 receptor antagonists 2008 ·Bioorganic & Medicinal Chemistry Letters ·Tae‐young Yoon,Stéphane De Lombaert,Robbin Brodbeck,Michael Gulianello,James E. Krause,Alan Hutchison,(unknown),Ping Ge,John H. Kehne,Diane C. Hoffman,Jayaraman Chandrasekhar,Darı́o Doller,Kevin J. Hodgetts	8
12	From arylureas to biarylamides to aminoquinazolines: Discovery of a novel, potent TRPV1 antagonist 2006 ·Bioorganic & Medicinal Chemistry Letters ·Xiaozhang Zheng,Kevin J. Hodgetts,Harry L. Brielmann,Alan Hutchison,(unknown),A. Brian Jones,Peter Blurton,R.B. Clarkson,Jayaraman Chandrasekhar,Rajagopal Bakthavatchalam,Stéphane De Lombaert,Marci Crandall,Daniel N. Cortright,Charles A. Blum	25
13	Inter- and intramolecular Mitsunobu reaction based approaches to 2-substituted chromans and chroman-4-ones 2005 ·Tetrahedron ·Kevin J. Hodgetts	62
14	2-Aryl-3,6-dialkyl-5-dialkylaminopyrimidin-4-ones as novel crf-1 receptor antagonists 2003 ·Bioorganic & Medicinal Chemistry Letters ·Kevin J. Hodgetts,Tae‐young Yoon,Jianhua Huang,Michael Gulianello,(unknown),Renee Primus,Robbin Brodbeck,Stéphane De Lombaert,Darı́o Doller	14
15	Synthesis of 2-Aryl-oxazolo[4,5-c]quinoline-4(5H)-ones and 2-Aryl-thiazolo[4,5-c]quinoline-4(5H)-ones 2003 ·Organic Letters ·Kevin J. Hodgetts,Mark T. Kershaw	54
16	3-Aryl pyrazolo[4,3-d]pyrimidine derivatives 2002 ·Bioorganic & Medicinal Chemistry Letters ·Jun Yuan,Michael Gulianello,Stéphane De Lombaert,Robbin Brodbeck,(unknown),Kevin J. Hodgetts	30
17	Indoline and piperazine containing derivatives as a novel class of mixed D2/D4 receptor antagonists. Part 1: Identification and structure–activity relationships 2002 ·Bioorganic & Medicinal Chemistry Letters ·He Zhao,Andrew Thurkauf,(unknown),Kevin J. Hodgetts,(unknown),Stanisław Rachwał,(unknown),Alan Hutchison,John Peterson,(unknown),Robbin Brodbeck,Renee Primus,Jan W. F. Wasley	21
18	6-(4-Benzylpiperazin-1-yl)benzodioxanes as selective ligands at cloned primate dopamine D4 receptors 2001 ·Bioorganic & Medicinal Chemistry ·Kevin J. Hodgetts,(unknown),Robbin Brodbeck,Jennifer Tran,Jan W. F. Wasley,Andrew Thurkauf	17
19	ChemInform Abstract: Preparation and Electrocyclic Ring‐Opening of Cyclobutenes: Stereocontrolled Approaches to Substituted Conjugated Dienes and Trienes. 1996 ·ChemInform ·Falmai Binns,Roy Hayes,Kevin J. Hodgetts,Suthiweth T. Saengchantara,Timothy W. Wallace,Christopher J. Wallis	1
20	Enantiocomplementary Routes to 6-Oxygenated (2Z,4E)-Alkadiene Precursors via Diastereoselective Reduction of 2-Cyclobuten-1-yl ketones 1995 ·Synlett ·Kevin J. Hodgetts,Christopher J. Wallis,Timothy W. Wallace	4

About Kevin J. Hodgetts

Kevin J. Hodgetts is a scholar working on Behavioral Neuroscience, Biological Psychiatry and Sensory Systems, having authored 32 papers that have together received 769 indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (5 papers), Neurogenetic and Muscular Disorders Research (5 papers) and RNA modifications and cancer (5 papers). The work is most often cited by research in Organic Chemistry (353 citations), Biological Psychiatry (24 citations) and Cellular and Molecular Neuroscience (134 citations). Kevin J. Hodgetts has collaborated with scholars based in United States, Ireland and United Kingdom. Frequent co-authors include Mark T. Kershaw, Elliot J. Androphy, Robbin Brodbeck, Stéphane De Lombaert, Chien‐liang Glenn Lin, Xuechao Xing, Gregory D. Cuny, Marcie A. Glicksman, Stephen P. Wren and Ling‐Chu Chang. Their work appears in journals such as The Journal of Experimental Medicine, Annals of Neurology and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact